Murine models of potassium channelopathies
- Authors: Akhmarov I.I.1, Kirillov O.A.1, Kandina D.A.1, Luganskaya P.S.1, Sopova J.V.1, Leonova E.I.1
-
Affiliations:
- Saint Petersburg State University
- Issue: Vol 24, No 1 (2026)
- Pages: 59-64
- Section: Genetically modified organism.history, achievements, social and environmental risks.
- Submitted: 31.10.2025
- Accepted: 08.02.2026
- Published: 31.03.2026
- URL: https://journals.eco-vector.com/ecolgenet/article/view/695534
- DOI: https://doi.org/10.17816/ecogen695534
- EDN: https://elibrary.ru/ZVUNKQ
- ID: 695534
Cite item
Abstract
Potassium channels constitute the most diverse group of ion channels and play a key role in regulating neuronal excitability and cardiac electrical activity. Despite significant progress in understanding their structure and function, the relationship between specific genetic alterations and disease phenotypes remains insufficiently systematized, which underscores the relevance of a comprehensive analysis of available data. This review summarizes findings from studies of animal models carrying mutations in potassium channel genes, aimed at elucidating their physiological roles and the molecular mechanisms of pathogenesis. Knockout models of kcna1, kcna2, and kcnq2 reproduce key features of human epileptic syndromes, including neuronal hyperexcitability, spontaneous seizures, and early mortality. Deficiency of kcnma1 is associated with impaired motor coordination and the development of cerebellar ataxia. Mutations in kcnq1 and kcne1 result in cardiac and auditory abnormalities characteristic of Jervell and Lange-Nielsen syndrome, whereas double knockout of kcne1/kcnh2 leads to a pronounced susceptibility to ventricular arrhythmias. In addition, deletion of kcnd2 and kcnd3, encoding Kv4 family channel subunits, reveals their critical role in shaping the early phase of cardiac repolarization. Thus, the systematization of data on genetically modified animal models enables the establishment of links between molecular defects in potassium channels and clinical manifestations of disease, and highlights their importance as tools for the development and testing of novel therapeutic approaches.
Keywords
Full Text
About the authors
Ilyas I. Akhmarov
Saint Petersburg State University
Author for correspondence.
Email: luvk7411@ya.ru
ORCID iD: 0009-0008-8920-6705
SPIN-code: 5952-4539
Center for Transgenesis and Genome Editing
Russian Federation, Saint PetersburgOleg A. Kirillov
Saint Petersburg State University
Email: o-kirillov03@mail.ru
ORCID iD: 0009-0004-3400-6678
SPIN-code: 7459-9945
Center for Transgenesis and Genome Editing
Russian Federation, Saint-PetersburgDaria A. Kandina
Saint Petersburg State University
Email: candyda20@mail.ru
ORCID iD: 0009-0007-4108-6161
SPIN-code: 7921-4448
Center for Transgenesis and Genome Editing
Russian Federation, Saint PetersburgPolina S. Luganskaya
Saint Petersburg State University
Email: polina.luganskaja@yandex.ru
ORCID iD: 0009-0005-1124-3360
SPIN-code: 1019-8610
Center for Transgenesis and Genome Editing
Russian Federation, Saint PetersburgJulia V. Sopova
Saint Petersburg State University
Email: sopova@hotmail.com
ORCID iD: 0000-0002-7825-273X
SPIN-code: 6019-1547
Cand. Sci. (Biology), Center for Transgenesis and Genome Editing
Russian Federation, Saint PetersburgElena I. Leonova
Saint Petersburg State University
Email: 1102.elena@gmail.com
ORCID iD: 0000-0002-0236-3302
SPIN-code: 2573-1759
Cand. Sci. (Biology), Center for Transgenesis and Genome Editing
Russian Federation, Saint PetersburgReferences
- Kuang Q, Purhonen P, Hebert H. Structure of potassium channels. Cell Mol Life Sci. 2015;72(19):3677–3693. doi: 10.1007/s00018-015-1948-5 EDN: KIABLH
- Weston MC, Tzingounis AV. Potassium channels in genetic epilepsy: a functional perspective. In: Noebels JL, Avoli M, Rogawski MA, editors. Jasper’s basic mechanisms of the epilepsies. 5th ed. Oxford University Press; 2024. P. 921–952. doi: 10.1093/med/9780197549469.003.0045
- Sanguinetti MC, Spector PS. Potassium channelopathies. Neuropharmacology. 1997;36(6):755–762. doi: 10.1016/s0028-3908(97)00029-4
- Kim DM, Nimigean CM. Voltage-gated potassium channels: a structural examination of selectivity and gating. Cold Spring Harb Perspect Biol. 2016;8(5):a029231. doi: 10.1101/cshperspect.a029231 EDN: WUENRD
- Smart SL, Lopantsev V, Zhang CL, et al. Deletion of the KV1.1 potassium channel causes epilepsy in mice. Neuron. 1998;20(4):809–819. doi: 10.1016/s0896-6273(00)81018-1
- Brew HM, Gittelman JX, Silverstein RS, et al. Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons. J Neurophysiol. 2007;98(3):1501–1525. doi: 10.1152/jn.00640.2006
- Brun L, Viemari J, Villard L. Mouse models of Kcnq2 dysfunction. Epilepsia. 2022;63(11):2813–2826. doi: 10.1111/epi.17405 EDN: ZHJRHB
- Miceli F, Soldovieri MV, Weckhuysen S, et al. KCNQ2-related disorders. In: Adam MP, Feldman J, Mirzaa GM, et al editors. GeneReviews®. Seattle: University of Washington; 1993.
- Mao M, Jancovski N, Kushner Y, et al. Developmental dysfunction in a preclinical model of Kcnq2 developmental and epileptic encephalopathy. Neurobiol Dis. 2025;205:106782. doi: 10.1016/j.nbd.2024.106782 EDN: XLCKNB
- Milh M, Roubertoux P, Biba N, et al. A knock-in mouse model for KCNQ2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment. Epilepsia. 2020;61(5):868–878. doi: 10.1111/epi.16494 EDN: KRQHWK
- Singh NA, Otto JF, Dahle EJ, et al. Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J Physiol. 2008;586(14):3405–3423. doi: 10.1113/jphysiol.2008.154971
- Bailey CS, Moldenhauer HJ, Park SM, et al. KCNMA1-linked channelopathy. J Gen Physiol. 2019;151(10):1173–1189. doi: 10.1085/jgp.201912457
- Sausbier M, Hu H, Arntz C, et al. Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency. PNAS USA. 2004;101(25):9474–9478. doi: 10.1073/pnas.0401702101
- Grandi E, Sanguinetti MC, Bartos DC, et al. Potassium channels in the heart: structure, function and regulation. J Physiol. 2017;595(7):2209–2228. doi: 10.1113/JP272864
- Casimiro MC, Knollmann BC, Ebert SN, et al. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange–Nielsen syndrome. PNAS USA. 2001;98(5):2526–2531. doi: 10.1073/pnas.041398998
- Vetter DE, Mann JR, Wangemann P, et al. Inner ear defects induced by null mutation of the isk gene. Neuron. 1996;17(6):1251–1264. doi: 10.1016/s0896-6273(00)80255-x.
- Drici M-D, Arrighi I, Chouabe C, et al. Involvement of IsK-associated K+ channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange–Nielsen syndrome. Circ Res. 1998;83(1):95–102. doi: 10.1161/01.res.83.1.95
- Kupershmidt S, Yang T, Anderson ME, et al. Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system. Circ Res. 1999;84(2):146–152. doi: 10.1161/01.res.84.2.146
- Salama G, Baker L, Wolk R, et al. Arrhythmia phenotype in mouse models of human long QT. J Interv Card Electrophysiol. 2009;24(2):77–87. doi: 10.1007/s10840-008-9339-6 EDN: KIECGK
- Guo W, Jung WE, Marionneau C, et al. Targeted deletion of Kv4.2 eliminates Ito,f and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res. 2005;97(12):1342–1350. doi: 10.1161/01.RES.0000196559.63223.aa
Supplementary files





